论文信息 - Efficacy and safety of 3‐month dosing regimen of degarelix in Japanese subjects with prostate cancer: A phase III study - 字舞流文

Efficacy and safety of 3‐month dosing regimen of degarelix in Japanese subjects with prostate cancer: A phase III study

Y. Ohashi | H. Akaza | S. Horie | S. Naito | T. Tsukamoto | H. Uemura | M. Saito | S. Fukasawa | S. Ozono | Y. Yokomizo | Rio Akazawa | H. Kusuoka